Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–12. https://doi.org/10.1016/j.jacc.2013.05.015.

Article  PubMed  Google Scholar 

Tarantini G, Mojoli M, Urena M, Vahanian A. Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome. Eur Heart J. 2017;38(17):1285–93. https://doi.org/10.1093/eurheartj/ehw456.

Article  CAS  PubMed  Google Scholar 

Ryan T, Grindal A, Jinah R, et al. New-onset atrial fibrillation after transcatheter aortic valve replacement. JACC: Cardiovasc Interventions. 2022;15(6):603–13. https://doi.org/10.1016/j.jcin.2022.01.018.

Article  Google Scholar 

Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in patients with Atrial Fibrillation. N Engl J Med. 2020;383(14):1305–16. https://doi.org/10.1056/NEJMoa2019422.

Article  PubMed  Google Scholar 

Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for Atrial Fibrillation with Heart failure. N Engl J Med. 2018;378(5):417–27. https://doi.org/10.1056/NEJMoa1707855.

Article  PubMed  Google Scholar 

Gillinov AM, Bagiella E, Moskowitz AJ, et al. Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac surgery. N Engl J Med. 2016;374(20):1911–21. https://doi.org/10.1056/NEJMoa1602002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167(4):492–9. https://doi.org/10.1093/aje/kwm324.

Article  PubMed  Google Scholar 

Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 update: a Report from the American Heart Association. Circulation. 2019;139(10):e56–528. https://doi.org/10.1161/cir.0000000000000659.

Article  PubMed  Google Scholar 

Prasad V, Jena AB. Prespecified falsification end points: can they validate true Observational associations? JAMA. 2013;309(3):241–2. https://doi.org/10.1001/jama.2012.96867.

Article  CAS  PubMed  Google Scholar 

Kim D, Yang P-S, You Seng C, et al. Age and outcomes of early rhythm control in patients with Atrial Fibrillation. JACC: Clin Electrophysiol. 2022;8(5):619–32. https://doi.org/10.1016/j.jacep.2022.02.014.

Article  PubMed  Google Scholar 

Dickow J, Kirchhof P, Van Houten HK, et al. Generalizability of the EAST-AFNET 4 Trial: assessing outcomes of early rhythm‐control therapy in patients with Atrial Fibrillation. J Am Heart Association. 2022;11(11):e024214. https://doi.org/10.1161/JAHA.121.024214.

Article  Google Scholar 

Dickow J, Kany S, Roth Cardoso V, et al. Outcomes of early rhythm control therapy in patients with Atrial Fibrillation and a high Comorbidity Burden in large real-world cohorts. Circ Arrhythm Electrophysiol. 2023;16(5):e011585. https://doi.org/10.1161/circep.122.011585.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rillig A, Borof K, Breithardt G, et al. Early Rhythm Control in patients with Atrial Fibrillation and High Comorbidity Burden. Circulation. 2022;146(11):836–47. https://doi.org/10.1161/circulationaha.122.060274.

Article  PubMed  Google Scholar 

Yu GI, Kim D, Sung JH, et al. Impact of frailty on early rhythm control outcomes in older adults with atrial fibrillation: a nationwide cohort study. Front Cardiovasc Med. 2022;9:1050744. https://doi.org/10.3389/fcvm.2022.1050744.

Article  PubMed  Google Scholar 

Feldman DR, Romashko MD, Koethe B, et al. Comorbidity Burden and adverse outcomes after transcatheter aortic valve replacement. J Am Heart Assoc. 2021;10(10):e018978. https://doi.org/10.1161/jaha.120.018978.

Article  PubMed  PubMed Central  Google Scholar 

January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):2071–104. https://doi.org/10.1161/cir.0000000000000040.

Article  PubMed  Google Scholar 

Chau KH, Douglas PS, Pibarot P, et al. Regression of Left Ventricular Mass after Transcatheter aortic valve replacement: the PARTNER trials and registries. J Am Coll Cardiol. 2020;75(19):2446–58. https://doi.org/10.1016/j.jacc.2020.03.042.

Article  PubMed  Google Scholar 

Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or Drug Therapy for initial treatment of Atrial Fibrillation. N Engl J Med. 2020;384(4):305–15. https://doi.org/10.1056/NEJMoa2029980.

Article  PubMed  Google Scholar 

Chew DS, Li Y, Cowper PA, et al. Cost-effectiveness of catheter ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: the CABANA Randomized Clinical Trial. Circulation. 2022;146(7):535–47. https://doi.org/10.1161/circulationaha.122.058575.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kneeland PP, Fang MC. Trends in catheter ablation for atrial fibrillation in the United States. J Hosp Med. 2009;4(7):E1–5. https://doi.org/10.1002/jhm.445.

Article  PubMed  Google Scholar 

Nademanee K, Amnueypol M, Lee F, et al. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation. Heart Rhythm. 2015;12(1):44–51. https://doi.org/10.1016/j.hrthm.2014.09.049.

Article  PubMed  Google Scholar 

Bahnson TD, Giczewska A, Mark DB, et al. Association between Age and outcomes of catheter ablation Versus Medical Therapy for Atrial Fibrillation: results from the CABANA Trial. Circulation. 2022;145(11):796–804. https://doi.org/10.1161/CIRCULATIONAHA.121.055297.

Article  PubMed  Google Scholar 

Vora Amit N, Dai D, Matsuoka R, et al. Incidence, management, and Associated Clinical outcomes of New-Onset Atrial Fibrillation following transcatheter aortic valve replacement. JACC: Cardiovasc Interventions. 2018;11(17):1746–56. https://doi.org/10.1016/j.jcin.2018.05.042.

Article  CAS  Google Scholar 

Kim D, Yang PS, Sung JH, et al. Effectiveness and safety of Anticoagulation Therapy in Frail patients with Atrial Fibrillation. Stroke. 2022;53(6):1873–82. https://doi.org/10.1161/strokeaha.121.036757.

Article  CAS  PubMed  Google Scholar 

Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–62. https://doi.org/10.1016/s0140-6736(13)62343-0.

Article  CAS  PubMed  Google Scholar 

Didier R, Lhermusier T, Auffret V, et al. TAVR patients requiring anticoagulation. JACC: Cardiovasc Interventions. 2021;14(15):1704–13. https://doi.org/10.1016/j.jcin.2021.05.025.

Article  Google Scholar 

Van Mieghem NM, Unverdorben M, Hengstenberg C, et al. Edoxaban versus vitamin K antagonist for Atrial Fibrillation after TAVR. N Engl J Med. 2021;385(23):2150–60. https://doi.org/10.1056/NEJMoa2111016.

Article  PubMed  Google Scholar 

Petersen JK, Fosbøl EL, Strange JE, et al. Impact of first-time detected atrial fibrillation after transcatheter aortic valve replacement: a nationwide study. IJC Heart Vasculature. 2023;47:101239. https://doi.org/10.1016/j.ijcha.2023.101239.

Article  PubMed  PubMed Central  Google Scholar 

Nso N, Emmanuel K, Nassar M, et al. Impact of new-onset versus pre-existing atrial fibrillation on outcomes after transcatheter aortic valve replacement/implantation. IJC Heart Vasculature. 2022;38:100910. https://doi.org/10.1016/j.ijcha.2021.100910.

Article  PubMed  PubMed Central  Google Scholar